Press release
Enzyme Replacement Therapy Market to Surge at 6.7% CAGR, Reaching US$13.8B by 2028 | FMI Inc.
Enzyme Replacement Therapy Market
Increasing per capita healthcare expenditure in North America is expected to push market revenue growth. The rapidly developing healthcare infrastructure and increasing awareness programmes in the highly populous regions of Asia Pacific and China is expected to play an important role in driving revenue growth of the global enzyme replacement therapy market.
Seize a mesmerizing sample report complete with captivating data visuals. @
https://www.futuremarketinsights.com/reports/sample/rep-gb-3167
Global Enzyme Replacement Therapy Market: Regional Insights
With nearly 25%-30% market share, North America dominated the global enzyme replacement therapy market in 2017, partly due to the presence of leading market players in the region. In developing regions such as Latin America, advancements in medical facilities are helping the region cope with healthcare crisis. Medical facilities in Brazil are equivalent with hospitals in the United States, with some even exceeding American standards. Brazil offers everything from large, full service hospitals to smaller, intimate private clinics.
Brazil has developed into a centre of excellence for healthcare in Latin America, with major universities that support research, teaching and training of medical professionals. Western Europe is the second largest market globally and is expected to be valued at US$ 2,893.2 Mn by 2028, with France, Italy and Spain projected to witness significant growth rates. Japan is expected to be the third largest market for enzyme replacement therapy.
Global Enzyme Replacement Therapy Markets: Segmentation & Forecast
The global enzyme replacement therapy markets has been segmented on the basis of therapeutic condition, route of administration, distribution channel and region. Therapeutic conditions in the enzyme replacement therapy markets include fabry disease, gaucher disease, mucopolysaccharidosis, pompe disease, lysosomal acid lipase deficiency and others.
Globally, the mucopolysaccharidosis therapeutic condition is the most attractive segment. Injectable segment remains the most lucrative route of administration in the enzyme replacement therapy markets. Among all distribution channels for enzyme replacement therapy, speciality treatment pharmacies are expected to be the most lucrative, followed by hospital pharmacies.
Key Research Findings
Enzyme replacement therapy is used in the treatment of rare diseases and the global market is projected to create incremental opportunity of US$ 6,448.3 Mn between 2022 and 2028
When compared to other established markets such as North America, the enzyme replacement therapy markets in Japan and Western Europe are expected to witness fast and steady growth, partly due to the increasing governmental support and growing demand for enzyme replacement therapy for the treatment of rare diseases.
Enrich your thinking with our comprehensive methodology now. @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-3167
Global Enzyme Replacement Therapy Market: Competitive Landscape
-Sanofi S.A. (Genzyme Corporation)
-Shire plc.
-Pfizer Inc.
-Alexion Pharmaceuticals Inc.
-BioMarin Pharmaceutical Inc.
-Ultragenyx Pharmaceutical Inc.
-Johnson & Johnson Services Inc.
-Allergan plc.
-Leadiant Biosciences Inc.
Pompe Disease Treatment Market Is a type of treatment for certain genetic diseases that are caused by a deficiency in a specific enzyme. This therapy involves administering the missing enzyme to the patient, usually through intravenous infusion.
Key Segments of Enzyme Replacement Therapy Industry Survey
Enzyme Replacement Therapy Market by Therapeutic Condition:
-Enzyme Replacement Therapy for Fabry Disease
-Enzyme Replacement Therapy for Gaucher Disease
>Enzyme Replacement Therapy for Mucopolysaccharidosis
--MPS I
--MPS II (Hunter Syndrome)
--MPS IVA (Morquio Syndrome, Type A)
--MPS VI (Maroteaux-Lamy Syndrome)
--MPS VII (Sly Syndrome)
-Enzyme Replacement Therapy for Pompe Disease
-Enzyme Replacement Therapy for Lysosomal Acid Lipase Deficiency
-Others
Enzyme Replacement Therapy Market by Route of Administration:
-Oral Enzyme Replacement Therapy
-Injectable Enzyme Replacement Therapy
Enzyme Replacement Therapy Market by Distribution Channel:
-Hospital Pharmacies
-Specialty Treatment Pharmacies
-Retail Pharmacies
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Contact Us:
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Read the Complete Research Now: @
https://www.futuremarketinsights.com/reports/enzyme-replacement-therapy-market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Enzyme Replacement Therapy Market to Surge at 6.7% CAGR, Reaching US$13.8B by 2028 | FMI Inc. here
News-ID: 3196774 • Views: …
More Releases from Future Market Insights Inc.
Oil & Gas Electrification Market Projected to Surge to USD 5 Billion by 2035, Dr …
The global oil & gas electrification market is set for remarkable expansion, with an estimated value of USD 2.1 billion in 2025 and a projected surge to USD 5.0 billion by 2035. This growth trajectory reflects a compound annual growth rate (CAGR) of 9.1%, driven by increasing investments in sustainable electrification technologies and heightened regulatory pressures aimed at reducing carbon emissions across the industry.
As the oil and gas sector faces…
Global Glassware Market to Reach USD 15.4 Billion by 2035, Driven by Rising Dema …
The global glassware market is on track to experience steady growth over the next decade, with a projected compound annual growth rate (CAGR) of 5.9% from 2025 to 2035. Valued at USD 8.7 billion in 2025, the market is expected to reach an impressive USD 15.4 billion by 2035. This growth is primarily attributed to the rising demand for high-quality, aesthetically appealing, and sustainable glassware products, particularly in the hospitality,…
nduction Hob Market Expected to Reach USD 58.2 Million by 2035, Driven by Growin …
The global Induction Hob Market is set to experience significant growth, with an estimated market value of USD 23.5 million in 2025 and a projected rise to USD 58.2 million by 2035, marking a compound annual growth rate (CAGR) of 9.5% over the forecast period. As consumers increasingly shift toward energy-efficient and technologically advanced cooking solutions, the induction hob sector is poised to benefit from a growing preference for safe,…
Automatic Bottle Opener Market to Reach USD 1.43 Billion by 2035, Driven by Cons …
The automatic bottle opener market is experiencing significant growth and is forecasted to reach USD 1.43 billion by 2035, up from USD 756.5 million in 2025. With a compound annual growth rate (CAGR) of 6.6%, the market is expected to evolve significantly over the next decade, propelled by the increasing popularity of automated home appliances and smart kitchen tools.
This surge is driven by the growing demand for convenient, easy-to-use solutions…
More Releases for Enzyme
Enzyme Replacement Therapy Market: Advancing Treatment for Inherited Enzyme Defi …
The Enzyme Replacement Therapy Market at a global level was worth USD 10.1 Billion in 2022 and is anticipated to expand to USD 20.6 Billion by 2032, experiencing a CAGR of 7.6% during the forecast period of 2023-2032.
The Enzyme Replacement Therapy (ERT) Market stands at the forefront of medical innovation, offering transformative treatment options for individuals with inherited enzyme deficiencies. Enzyme replacement therapy involves the infusion of artificial enzymes into…
Anti-Inflammatory Activity Enzyme and Protease Enzyme | Pearlzyme Inc
Pearlzyme Inc. focuses on boosting animal immune systems against infection and increasing milk lactation with anti-inflammatory activity enzymes. Also enzyme feed additives demonstrates a commitment to improving animal health and productivity. By developing innovative products, the company aims to provide effective solutions to its customers.
Pearlzyme Inc is committed to sustainable development and reducing environmental impact. As an environmentally conscious company, it recognizes the importance of minimizing its footprint and contributing…
Meat Tenderizing Agents Market 2018 Flourishes with International Prestigious Pl …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Meat Tenderizing Agents Market 2018 Flourishes with International Prestigious Pl …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Meat Tenderizing Agents Market Global Leader | Enzyme Bioscience Pvt. Ltd, AB En …
Market Overview:
Tenderizing is a process so as to to reduce the toughness of meat fibers in a cut of meat. Tenderizing agents breaks down the meat collagen and softens the meat. The tenderness of meat depends on various factors including the meat grain, the amount of connective tissue, and the fat %. Tenderness can be improved by various techniques, generally enzymes and acids are used in this process. Enzymes…
Enzymes in Biofuel Market Research Report 2018 | Biofuel Enzyme, Schaumann Bioen …
Researchmoz added Most up-to-date research on "Global Enzymes in Biofuel Market Research Report 2018" to its huge collection of research reports.
This report studies the global Enzymes in Biofuel market status and forecast, categorizes the global Enzymes in Biofuel market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
The…
